Article

A Novel Therapy for ALS: Allogeneic Schwann Cell Extracellular Vesicles

2023-01-23

Abstract excerpt

<h4>Summary</h4> Amyotrophic Lateral Sclerosis (ALS) is a terminal condition with accelerated loss of motor neurons (MN), resulting in the progressive paralysis of affected patients. ALS is either sporadic (90%) or genetically transmitted (10%) and affects cortical (pyramidal) and spinal cord (lower) MN, axons, and respective muscle endplates. ALS research has focused on MN survival, and current FDA-approved thera...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6a953312-5d0c-5416-93ae-018cc3ba5adb
DOI: 10.1101/2023.01.18.23284378

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Novel Therapy for ALS: Allogeneic Schwann Cell Extracellular VesiclesDOI 10.1101/2023.01.18.23284378Read

Recent Advances in Extracellular Vesicles in Amyotrophic Lateral Sclerosis and Emergent PerspectivesSemantic proximity Read

Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model.Semantic proximity Read

Sema3A Facilitates a Retrograde Death Signal via CRMP4-Dynein Complex Formation in ALS Motor AxonsSemantic proximity Read

Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosisSemantic proximity Read

Comparison of AAV9-driven motor neuron transduction following different CNS-directed delivery methods in miceSemantic proximity Read

Clinical outcome of the Intrathecal administration of the allogeneic side population Adipose Derived Mesenchymal Stem Cells in Werdnig Hoffman patients: An open-label Phase I clinical trialSemantic proximity Read

In vivo self-assembled SOD1-siRNAs mitigate muscle atrophy and denervation in amyotrophic lateral sclerosisSemantic proximity Read

A Phase 2A randomized, double-blind, placebo-controlled pilot trial of GM604 in patients with Amyotrophic Lateral Sclerosis (ALS Protocol GALS-001) and a single compassionate patient treatment (Protocol GALS-C)Semantic proximity Read

Olfactory ensheathing cell transplantation into spinal cord prolongs the survival of mutant SOD1(G93A) ALS rats through neuroprotection and remyelination.Semantic proximity Read

Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.Semantic proximity Read

Enhanced axonal regeneration of ALS patient iPSC-derived motor neurons harboring SOD1A4V mutation.Semantic proximity Read

Foetal Allogeneic Intracerebroventricular Neural Stem Cell Transplantation in People with Secondary Progressive Multiple Sclerosis: A phase I dose-escalation clinical trialSemantic proximity Read